Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.
Hie, Miguel; Gay, Julie; Galicier, Lionel; Provôt, François; Presne, Claire; Poullin, Pascale; Bonmarchand, Guy; Wynckel, Alain; Benhamou, Ygal; Vanhille, Philippe; Servais, Aude; Bordessoule, Dominique; Coindre, Jean-Philippe; Hamidou, Mohamed; Vernant, Jean-Paul; Veyradier, Agnès; Coppo, Paul.
; 124(2): 204-10, 2014 Jul 10.
Artigo em Inglês | MEDLINE | ID: mdl-24869941
Pathophysiology of thrombotic thrombocytopenic purpura.
Thrombotic thrombocytopenic purpura in children.
Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.
Congenital and acquired ADAMTS13 deficiency: Two mechanisms, one patient.
Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
Thrombotic thrombocytopenic purpura: from diagnosis to therapy.
Serial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura.
Pregnancy associated thrombotic thrombocytopenic purpura: Practical issues for patient management.
[Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].